Business Segments

12 Months Ended

Dec. 31, 2014

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 7 - Business Segments

The Company is made up of two operation segments: Death Care and Enzyme. Before June 2014, the Company was engaged in selling enzymes products to public consumers in Taiwan. Beginning in June 2014, the Company began providing death care management consultancy services to consumers across Taiwan.

The balance sheets information as of December 31, 2014 and December 31, 2013 and the income statement information for the years ended December 31, 2014 and 2013 of each segment is presented in US Dollars as follows:

	December 31, 2014								December 31, 2013
	Death Care		Enzyme		Corporate		Total		Death Care		Enzyme		Corporate		Total
Current assets	$	6,808	$	870	$	7,243	$	14,921	$	-	$	-	$	11,795	$	11,795
Fixed assets		-		-		-		-		-		-		27,456		27,456
Total assets	$	6,808	$	870	$	7,243	$	14,921	$	-	$	-	$	39,251	$	39,251
Current liabilities	$	-	$	119,520	$	154,117	$	273,637	$	-	$	2,098	$	149,924	$	152,022
Intercompany		-		-		-		-		-		92,828		(92,828)		-
Stockholders' equity (deficit)		6,808		(118,650)		(146,874)		(258,716)		-		(94,926)		(17,845)		(112,771)
Total liabilities and stockholders' equity  (deficit)	$	6,808	$	870	$	7,243	$	14,921	$	-	$	-	$	39,251	$	39,251

	For the year ended December 31, 2014								For the year ended December 31, 2013
	Death Care		Enzyme		Corporate		Total		Death Care		Enzyme		Corporate		Total
Revenues	$	16,500	$	1,556	$	-	$	18,056	$	-	$	24,741	$	-	$	24,741
Cost of revenues		-		652		-		652		-		10,142		-		10,142
Gross profit		16,500		904		-		17,404		-		14,599		-		14,599
Operating expenses		9,692		24,628		127,493		161,813		-		116,861		67,877		184,738
Other incomes (expenses)		-		-		(1,427)		(1,427)		-		-		(734)		(734)
Net income (loss)	$	6,808	$	(23,724)	$	(128,920)	$	(145,836)	$	-	$	(102,262)	$	(68,611)	$	(170,873)